Sanofi
corporate_fare Company Profile
Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 48 items for SNY at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Sanofi's Efdoralprin Alfa Outperforms Standard Therapy in Phase 2 AATD Trial
- Sanofi Appoints Belén Garijo as CEO, Declares €4.12 Dividend, and Welcomes New Director
- Sanofi Prices €2.3 Billion Multi-Tranche Bond Issue for General Corporate Purposes
- Sanofi Secures Key FDA Approvals for Dupixent and Tzield, Despite Sarclisa Delay
- EU Regulators Recommend Sanofi's Cenrifki for Secondary Progressive MS Approval
Financial Snapshot
Insider Transactions
SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.